OMEROS CORP Common Stock, Value, Issued
OMEROS CORP (OMER) had Common Stock, Value, Issued of $721.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-12
- 2026-06-30: Common Stock, Value, Issued $721.00K.
- 2026-03-31: Common Stock, Value, Issued $720.00K.
- 2025-12-31: Common Stock, Value, Issued $716.00K.
- 2025-09-30: Common Stock, Value, Issued $700.00K.
| Period end | Common Stock, Value, Issued |
|---|---|
| 2026-06-30 | $721.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $720.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $716.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $700.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $599.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $580.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $580.00K 10-K · filed 2026-03-31 |
| 2024-09-30 | $579.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $579.00K 10-Q · filed 2024-08-07 |
| 2024-03-31 | $579.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $611.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $628.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $628.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $628.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $628.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $627.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $627.00K 10-Q · filed 2022-08-09 |
| 2022-03-31 | $627.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $626.00K 10-K · filed 2023-03-13 |
| 2021-09-30 | $625.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $624.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $622.00K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $616.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $616.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $545.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $545.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $542.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $495.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $492.00K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $490.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $490.00K 10-K · filed 2020-03-02 |
| 2018-09-30 | $490.00K 10-Q · filed 2018-11-08 |
| 2018-06-30 | $485.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $483.00K 10-Q · filed 2018-05-10 |
| 2017-12-31 | $482.00K 10-K · filed 2019-03-01 |
| 2017-09-30 | $480.00K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $444.00K 10-Q · filed 2017-08-08 |
| 2017-03-31 | $439.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $438.00K 10-K · filed 2018-03-01 |
| 2016-09-30 | $429.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $393.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $391.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $380.00K 10-K · filed 2017-03-16 |
| 2015-09-30 | $380.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $379.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $378.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $342.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | $340.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $340.00K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $339.00K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $304.00K 10-K · filed 2015-03-16 |
| 2013-09-30 | $298.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $298.00K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $259.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $259.00K 10-K · filed 2014-03-13 |
| 2012-09-30 | $259.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $225.00K 10-Q · filed 2012-08-07 |
| 2012-03-31 | $225.00K 10-Q · filed 2012-05-10 |
| 2011-12-31 | $224.00K 10-K · filed 2013-03-18 |
| 2011-09-30 | $223.00K 10-Q · filed 2011-11-08 |
| 2011-06-30 | $222.00K 10-Q · filed 2011-08-09 |
| 2010-12-31 | $219.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |